Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Toxicology and Environmental Health. Part A|June 27, 2003
Susceptibility of lupus-prone NZM mouse strains to lead exacerbation of systemic lupus erythematosus symptomsChad A Hudson, Ling Cao, Jane Kasten-Jolly, et al.
Journal of Virology|November 7, 2008
Modulation of macrophage infiltration and inflammatory activity by the phosphatase SHP-1 in virus-induced demyelinating diseaseGeorge P Christophi, Chad A Hudson, Michael Panos, et al.
Journal of Neuroimmunology|December 13, 2006
Antibody induction of lupus-like neuropsychiatric manifestationsDavid A Lawrence, Valerie J Bolivar, Chad A Hudson, et al.
Journal of Leukocyte Biology|June 17, 2008
Induction of IL-33 expression and activity in central nervous system gliaChad A Hudson, George P Christophi, Ross C Gruber, et al.
Clinical Immunology (Orlando, Fla.)|June 30, 2009
Interferon-beta treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1George P Christophi, Michael Panos, Chad A Hudson, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 23, 2008
SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patientsGeorge P Christophi, Chad A Hudson, Ross C Gruber, et al.
Glia|April 29, 2015
The control of reactive oxygen species production by SHP-1 in oligodendrocytesRoss C Gruber, Daria LaRocca, Scott B Minchenberg, et al.
Transfusion|May 17, 2020
Evaluation of the procoagulant properties of a newly developed platelet modified lysate productMajed A Refaai, Grace W Conley, Chad A Hudson, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 29, 2009
Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotypeGeorge P Christophi, Michael Panos, Chad A Hudson, et al.
Pageof 3